Dr John McMurray Compares EMPEROR-Reduced Findings with DAPA-HF
Having 2 trials that both show benefits of SGLT2 inhibitors in heart failure hospitalizations can only encourage the use of these drugs, said John McMurray, MD, FRCP, FESC, professor of medical cardiology in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow.
Watch video Dr John McMurray Compares EMPEROR-Reduced Findings with DAPA-HF online, duration hours minute second in high quality that is uploaded to the channel AJMCtv MJH 31 August 2020. Share the link to the video on social media so that your subscribers and friends will also watch this video. This video clip has been viewed 1,924 times and liked it 12 visitors.
